These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9915037)

  • 21. Hepatitis B Vaccine in national immunization schedule: a preventive step in India.
    Verma R; Khanna P; Prinja S; Rajput M; Chawla S; Bairwa M
    Hum Vaccin; 2011 Dec; 7(12):1387-8. PubMed ID: 22134433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009?
    Mereckiene J; Cotter S; Lopalco P; D'Ancona F; Levy-Bruhl D; Giambi C; Johansen K; Dematte L; Salmaso S; Stefanoff P; O'Flanagan D
    Vaccine; 2010 Jun; 28(28):4470-7. PubMed ID: 20451643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination.
    Zhang L; Xu A; Yan B; Song L; Li M; Xiao Z; Xu Q; Li L
    Int J Infect Dis; 2010 Jun; 14(6):e483-8. PubMed ID: 19939719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs.
    Palmateer NE; Goldberg DJ; Munro A; Taylor A; Yeung A; Wallace LA; Mitchell A; Shepherd SJ; Gunson RN; Aitken C; Hutchinson SJ
    Addiction; 2018 Jan; 113(1):80-90. PubMed ID: 28710874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The sustainability of hepatitis B immunization within the Universal Immunization Programme in India.
    Dasgupta R; Priya R
    Health Policy Plan; 2002 Mar; 17(1):99-105. PubMed ID: 11861591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public vaccination programmes against hepatitis B in The Netherlands: assessing whether a targeted or a universal approach is appropriate.
    Houweling H; Wittevrongel CF; Verweij M; Ruitenberg EJ;
    Vaccine; 2010 Nov; 28(49):7723-30. PubMed ID: 20933042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B vaccination in countries with low endemicity.
    Prescrire Int; 2000 Feb; 9(45):213-9. PubMed ID: 11503803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparing for the next public debate: universal vaccination against hepatitis B.
    Houweling H; Spaendonck MC; Paulussen T; Verweij M; Ruitenberg EJ
    Vaccine; 2011 Nov; 29(48):8960-4. PubMed ID: 21945254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in the hepatitis B related burden of disease--measuring the success of universal immunisation programs.
    Williams A
    Commun Dis Intell Q Rep; 2002; 26(3):458-60. PubMed ID: 12416714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [WHO spearheads global initiative to eradicate hepatitis B].
    Sylvan S
    Lakartidningen; 2000 Aug; 97(35):3738-40. PubMed ID: 11016226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global progress towards universal childhood hepatitis B vaccination, 2003.
    Wkly Epidemiol Rec; 2003 Oct; 78(42):366-70. PubMed ID: 14587209
    [No Abstract]   [Full Text] [Related]  

  • 32. Control of hepatitis B in the United Kingdom.
    Ramsay M; Gay N; Balogun K; Collins M
    Vaccine; 1998 Nov; 16 Suppl():S52-5. PubMed ID: 9915036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
    Kao JH
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination against hepatitis B in low endemic countries.
    Kretzschmar M; de Wit GA; Smits LJ; van de Laar MJ
    Epidemiol Infect; 2002 Apr; 128(2):229-44. PubMed ID: 12002541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends of hepatitis B notification rates in Turkey, 1990 to 2012.
    Ay P; Torunoglu MA; Com S; Çipil Z; Mollahaliloğlu S; Erkoc Y; Dilmen U
    Euro Surveill; 2013 Nov; 18(47):. PubMed ID: 24300883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed introduction of the birth dose of Hepatitis B vaccine in EPI programs in East Africa: a missed opportunity for combating vertical transmission of Hepatitis B.
    Bodo B; Malande OO
    Pan Afr Med J; 2017; 27(Suppl 3):19. PubMed ID: 29296154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiology of viral hepatitis].
    Kaić B; Vilibić-Cavlek T; Filipović SK; Nemeth-Blazić T; Pem-Novosel I; Vucina VV; Simunović A; Zajec M; Radić I; Pavlić J; Glamocanin M; Gjenero-Margan I
    Acta Med Croatica; 2013 Oct; 67(4):273-9. PubMed ID: 24984326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress toward elimination of hepatitis B virus transmission in the United States.
    Mast EE; Mahoney FJ; Alter MJ; Margolis HS
    Vaccine; 1998 Nov; 16 Suppl():S48-51. PubMed ID: 9915035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.